Sarcopenia: revised European consensus on definition and diagnosis
2018/09/24 by Alfonso J. Cruz‐Jentoft, Alfonso J Cruz-Jentoft, Gülistan Bahat +42 · 92 citations
Medicine · #Nutrition and Health in Aging #Body Composition Measurement Techniques #Frailty in Older Adults
paper · pdf · doi:10.1093/ageing/afy169
Abstract
Background: in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia. In early 2018, the Working Group met again (EWGSOP2) to update the original definition in order to reflect scientific and clinical evidence that has built over the last decade. This paper presents our updated findings. Objectives: to increase consistency of research design, clinical diagnoses and ultimately, care for people with sarcopenia. Recommendations: sarcopenia is a muscle disease (muscle failure) rooted in adverse muscle changes that accrue across a lifetime; sarcopenia is common among adults of older age but can also occur earlier in life. In this updated consensus paper on sarcopenia, EWGSOP2: (1) focuses on low muscle strength as a key characteristic of sarcopenia, uses detection of low muscle quantity and quality to confirm the sarcopenia diagnosis, and identifies poor physical performance as indicative of severe sarcopenia; (2) updates the clinical algorithm that can be used for sarcopenia case-finding, diagnosis and confirmation, and severity determination and (3) provides clear cut-off points for measurements of variables that identify and characterise sarcopenia. Conclusions: EWGSOP2's updated recommendations aim to increase awareness of sarcopenia and its risk. With these new recommendations, EWGSOP2 calls for healthcare professionals who treat patients at risk for sarcopenia to take actions that will promote early detection and treatment. We also encourage more research in the field of sarcopenia in order to prevent or delay adverse health outcomes that incur a heavy burden for patients and healthcare systems.
Citations
Cited by
- Resistance exercise as a treatment for sarcopenia: prescription and delivery
- Higher dietary protein intake is associated with sarcopenia in older British twins
- World guidelines for falls prevention and management for older adults: a global initiative
- Sarcopenia definition, diagnosis and treatment: consensus is growing
- ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease
- Prehabilitation, enhanced recovery after surgery, or both? A narrative review
- Nutritional and exercise interventions in individuals with sarcopenic obesity around retirement age: a systematic review and meta-analysis
- Pathophysiology of sarcopenia: Genetic factors and their interplay with environmental factors
- Anti-sarcopenic effects of active vitamin D through modulation of anabolic and catabolic signaling pathways in human skeletal muscle: A randomized controlled trial
- Nutrition in the prevention and treatment of skeletal muscle ageing and sarcopenia: a single nutrient, a whole food and a whole diet approach
- The effects of omega-3 polyunsaturated fatty acids on muscle and whole-body protein synthesis: a systematic review and meta-analysis
- Bioelectrical impedance analysis (BIA) -derived phase angle in sarcopenia: A systematic review
- ESPEN guideline on clinical nutrition in surgery – Update 2025
- Hallmarks of ageing in human skeletal muscle and implications for understanding the pathophysiology of sarcopenia in women and men
- Imaging-based assessment of sarcopenia in liver transplant candidates: A systematic review
- Development and validation of a new equation based on plasma creatinine and muscle mass assessed by CT scan to estimate glomerular filtration rate: a cross-sectional study
- Augmented Reality-Based Exercise for Older Adults: A Randomized Controlled Trial on Physical Function and Mobility
- The Prevalence of Weak Handgrip Strength in Ambulatory Oncology Patients and its Relationship with Quality of Life
- Type 1 diabetes, ageing and frailty: an underexplored intersection
- Resistance Training for Older Adults: Position Statement From the National Strength and Conditioning Association
- Sex-Specific Associations of Limb Muscle Strength, Mass, and Quality With Physical Performance in Older Adults: Handgrip and Chair Stand Tests
- Relationship between smoking and the incidence of sarcopenia: The SarcoPhAge cohort
- Loneliness and performance-based measures of physical function: coordinated meta-analytic findings from six cohorts
- Sarcopenia, myosteatosis, and frailty parameters to predict adverse outcomes in patients undergoing emergency laparotomy: prospective observational multicentre cohort study
- Effects of Supplemental Vitamin D3, Omega-3 Fatty Acids on Physical Performance Measures in the VITamin D and OmegA-3 TriaL
- Tissue-resident skeletal muscle macrophages promote recovery from viral pneumonia-induced sarcopenia in normal aging
- Personalized Combination of a Ketogenic Diet and Low-Dose Semaglutide for Cardiometabolic Health: A Retrospective Case Series
- Changes in the Muscle Strength in a Cohort of Community-Dwelling Older Adults in Brazil Over 6 Years
- Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
- Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR)
- Are we making progress in the diagnosis and management of sarcopenia? Results from a UK-wide survey
- Vascular Impairment, Muscle Atrophy, and Cognitive Decline: Critical Age-Related Conditions
- Physical fitness and physical activity in psoriatic arthritis: a systematic review
- HouShiHeiSan attenuates sarcopenia in middle cerebral artery occlusion (MCAO) rats
- Plasma metabolomics of an oral protein tolerance test reveals altered amino acid handling in sarcopenia
- Association of the Dietary Plant-To-Animal Protein Intake Ratio with the Incidence of Slow Gait Speed in Older Adults
- Sarcopenia and MASLD: novel insights and the future
- Roles of plasminogen activator inhibitor-1 in aging-related muscle and bone loss in mice
- Glucagon-like peptide-1 receptor agonists and muscle health: potential role in sarcopenia prevention and treatment
- Can simple measures from clinical practice serve as a proxy for sarcopenic obesity and identify mortality risk?
- Changes in body composition and handgrip strength during dapagliflozin administration in patients with chronic kidney disease
- Prospective associations between changes in physical activity and sedentary time and subsequent lean muscle mass in older English adults: the EPIC-Norfolk cohort study
- Multimodal (Bio)Markers and Risk of Obesity – A Comprehensive Scoping Review
- Improving sarcopenia in older adults: a systematic review and meta-analysis of randomized controlled trials of whey protein supplementation with or without resistance training
- Beyond Sarcopenia: A Systematic Review and Meta‐Analysis on Muscle Outcomes After Bariatric Surgery
- Addressing undernutrition in older adults with plant-based products
- CT evaluation for sarcopenia involving the psoas and paravertebral muscles in patients with total hip arthroplasty
- Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
- Deep Learning-Assisted Detection of Sarcopenia in Cross-Sectional Computed Tomography Imaging
- Prevalence and Impact of Sarcopenia in Chronic Pancreatitis: A Review of the Literature
- Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review
- Fat quantification in dual-layer detector spectral computed tomography : experimental development and first in-patient validation
- Cutoff points for handgrip strength in patients with liver cirrhosis: a multicenter study
- CD36 regulates myogenic differentiation via chronic integrated stress response – implications for muscle aging
- Associations between body composition and autonomic cardiorespiratory modulation in young adults
- Machine Learning Applications and Sarcopenia
- Musculoskeletal Health in Ageing Transgender and Gender Diverse Women: A Pilot Study
- Effects of intensity and modality of community-based exercise programs on mood profile and functional physical capacity in older women under socioeconomic vulnerability: A randomized trial
- Exercise training improves sarcopenic muscle function via restoration of mitochondrial quality control
- Malnutrition, Sarcopenia, and Malnutrition Sarcopenia Syndrome in Idiopathic Pulmonary Fibrosis
- Associations of accelerometer-derived ‘weekend warrior’ physical activity pattern with incident sarcopenia and falls
- Nutritional Assessment Tools for Patients with Cancer: A Narrative Review
- Why Osteosarcopenia Matters: Clinical and Investigative Implications
- Osseous manifestations of sarcoidosis
- Associations of Creatinine Muscle Index with markers of sarcopenia and mortality in chronic kidney disease: A prospective cohort study
- Quantification of skeletal muscle mass: sarcopenia as a marker of overall health in children and adults
- Automated Muscle and Fat Segmentation in Computed Tomography for Comprehensive Body Composition Analysis
- Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia. [europepmc]
- Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. [europepmc]
- Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD + Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. [europepmc]
- Sarcopenia: A Time for Action. An SCWD Position Paper. [europepmc]
- Skeletal muscle as potential central link between sarcopenia and immune senescence. [europepmc]
- Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. [europepmc]
- Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia. [europepmc]
- Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium. [europepmc]
- Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers. [europepmc]
- Sarcopenia: A Contemporary Health Problem among Older Adult Populations. [europepmc]
- Sarcopenia in chronic kidney disease: what have we learned so far? [europepmc]
- A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks. [europepmc]
- A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors. [europepmc]
- Role of Insulin Resistance in MAFLD. [europepmc]
- The Spectrum of Malnutrition/Cachexia/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review. [europepmc]
- Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. [europepmc]
- Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. [europepmc]
- International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines. [europepmc]
- Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. [europepmc]
- Associated Factors of Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis. [europepmc]
- The landscape of aging. [europepmc]
- Biomarkers of aging. [europepmc]
- Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. [europepmc]
- Sarcopenia and Cardiovascular Diseases. [europepmc]
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review. [europepmc]
Related